These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37068773)

  • 21. Rosacea is associated with Helicobacter pylori: a systematic review and meta-analysis.
    Jørgensen AR; Egeberg A; Gideonsson R; Weinstock LB; Thyssen EP; Thyssen JP
    J Eur Acad Dermatol Venereol; 2017 Dec; 31(12):2010-2015. PubMed ID: 28543746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of Association Found between Helicobacter pylori Infection and Diarrhea-Predominant Irritable Bowel Syndrome: A Multicenter Retrospective Study.
    Xiong F; Xiong M; Ma Z; Huang S; Li A; Liu S
    Gastroenterol Res Pract; 2016; 2016():3059201. PubMed ID: 27493660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fecal Microbiota Transplantation for Patients With Irritable Bowel Syndrome: A Meta-Analysis of Randomized Controlled Trials.
    Zhao HJ; Zhang XJ; Zhang NN; Yan B; Xu KK; Peng LH; Pan F
    Front Nutr; 2022; 9():890357. PubMed ID: 35719141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association Between
    Wu X; Zheng Y; Gao X; Li G; Cao Q
    Otolaryngol Head Neck Surg; 2020 Oct; 163(4):654-661. PubMed ID: 32482139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Helicobacter pylori eradication therapy for functional dyspepsia: Systematic review and meta-analysis.
    Du LJ; Chen BR; Kim JJ; Kim S; Shen JH; Dai N
    World J Gastroenterol; 2016 Mar; 22(12):3486-95. PubMed ID: 27022230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Prevalence of Irritable Bowel Syndrome after Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Their Association: A Systematic Review and Meta-Analysis of Observational Studies.
    Wang Z; Peng Y; Chen M; Peng L; Huang Y; Lin W
    J Clin Med; 2023 Feb; 12(5):. PubMed ID: 36902651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimum duration of regimens for Helicobacter pylori eradication.
    Yuan Y; Ford AC; Khan KJ; Gisbert JP; Forman D; Leontiadis GI; Tse F; Calvet X; Fallone C; Fischbach L; Oderda G; Bazzoli F; Moayyedi P
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008337. PubMed ID: 24338763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of
    Lu Y; Xiao F; Wang Y; Wang Z; Liu D; Hong F
    Front Oncol; 2022; 12():850389. PubMed ID: 35592678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials.
    Rahimi R; Nikfar S; Abdollahi M
    Clin Ther; 2008 May; 30(5):884-901. PubMed ID: 18555935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between
    Wang T; Li X; Zhang Q; Ge B; Zhang J; Yu L; Cai T; Zhang Y; Xiong H
    BMJ Open; 2019 Jun; 9(6):e027356. PubMed ID: 31248924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tegaserod for the treatment of irritable bowel syndrome.
    Evans BW; Clark WK; Moore DJ; Whorwell PJ
    Cochrane Database Syst Rev; 2004; (1):CD003960. PubMed ID: 14974049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acupuncture for treatment of irritable bowel syndrome.
    Manheimer E; Cheng K; Wieland LS; Min LS; Shen X; Berman BM; Lao L
    Cochrane Database Syst Rev; 2012 May; 5(5):CD005111. PubMed ID: 22592702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Helicobacter pylori infection and functional dyspepsia. Meta-analysis of efficacy of eradication therapy].
    Gisbert JP; Calvet X; Gabriel R; Pajares JM
    Med Clin (Barc); 2002 Mar; 118(11):405-9. PubMed ID: 11943102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The efficacy of adjuvant N acetyl cysteine for the eradication of H pylori infections: A systematic review and meta-analysis of randomized clinical trials.
    Biswas DP; Tk DS
    Clin Res Hepatol Gastroenterol; 2022 Mar; 46(3):101832. PubMed ID: 34775122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Colorectal cancer risk in East Asian patients with Helicobacter pylori infection: A systematic review and meta-analysis.
    Ma L; Guo W; Zeng Z; Yang F; Tang S; Ling Y
    Medicine (Baltimore); 2023 Mar; 102(10):e33177. PubMed ID: 36897722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of Colorectal Cancer in Patients With Irritable Bowel Syndrome: A Meta-Analysis of Population-Based Observational Studies.
    Wu X; Wang J; Ye Z; Wang J; Liao X; Liv M; Svn Z
    Front Med (Lausanne); 2022; 9():819122. PubMed ID: 35308554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors associated with irritable bowel syndrome and
    Shaheen MMA; Hroub M; Talahmeh L
    J Int Med Res; 2024 May; 52(5):3000605241248041. PubMed ID: 38775336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mind-Body Interventions for Irritable Bowel Syndrome Patients in the Chinese Population: a Systematic Review and Meta-Analysis.
    Wang W; Wang F; Fan F; Sedas AC; Wang J
    Int J Behav Med; 2017 Apr; 24(2):191-204. PubMed ID: 27646279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Prevalence of Irritable Bowel Syndrome Among Chinese University Students: A Systematic Review and Meta-Analysis.
    Yang W; Yang X; Cai X; Zhou Z; Yao H; Song X; Zhao T; Xiong P
    Front Public Health; 2022; 10():864721. PubMed ID: 35493361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The efficacy and safety of rifaximin for the irritable bowel syndrome: a systematic review and meta-analysis.
    Menees SB; Maneerattannaporn M; Kim HM; Chey WD
    Am J Gastroenterol; 2012 Jan; 107(1):28-35; quiz 36. PubMed ID: 22045120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.